Skip to content

Advertisement

BMC Geriatrics

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Tube feeding decreases pneumonia rate in patients with severe dementia: comparison between pre- and post-intervention

  • Shintaro Takenoshita1,
  • Keiko Kondo2,
  • Keiichi Okazaki3,
  • Akihiko Hirao4,
  • Keiko Takayama5,
  • Keisuke Hirayama6,
  • Hiroyuki Asaba7,
  • Kenji Nakata8,
  • Hideki Ishizu9,
  • Hiromi Takahashi10,
  • Hanae Nakashima-Yasuda10,
  • Yasue Sakurada10,
  • Kengo Fujikawa11,
  • Osamu Yokota11,
  • Norihito Yamada1,
  • Seishi Terada1Email author and
  • Middle Western Japan-Dementia Study (mid-Dem study)
BMC GeriatricsBMC series – open, inclusive and trusted201717:267

https://doi.org/10.1186/s12877-017-0662-6

Received: 19 July 2017

Accepted: 10 November 2017

Published: 21 November 2017

Abstract

Background

It is widely supposed that there is no benefit, including extended survival and decreased rate of pneumonia, in patients with severe dementia receiving enteral tube feeding (TF). However, there have been few studies comparing the frequency of pneumonia before and after TF in severe dementia.

Methods

Nine psychiatric hospitals in Okayama Prefecture participated in this retrospective survey. All inpatients fulfilling the entry criteria were evaluated. All subjects suffered from difficulty in oral intake. Attending physicians thought that the patients could not live without long-term artificial nutrition, and they decided whether or not to make use of long-term artificial nutrition from January 1, 2014 to December 31, 2014.

Results

We evaluated 58 patients including 46 with TF and 12 without. The mean age of all patients was 79.6 ± 9.0 years old. Patients with probable Alzheimer’s disease (n = 38) formed the biggest group, and those with vascular dementia the second (n = 14). Median survival times were 23 months among patients with TF and two months among patients without TF. The start of TF decreased the frequency of pneumonia and the use of intravenous antibiotics.

Conclusions

TF decreased pneumonia and antibiotic use, even in patients with severe dementia. The results of this study do not necessarily indicate that we should administer TF to patients with severe dementia. We should consider the quality of life of patients carefully before deciding the use or disuse of TF for patients with severe dementia.

Keywords

DementiaNasogastric tubePercutaneous endoscopic gastrostomyPneumoniaTube feeding

Background

The number of patients with dementia is rising remarkably in Japan. In most patients with severe dementia, difficulties in eating and/or swallowing occur [1], but the decision-making capacity of patients with severe dementia is lost in almost all cases [2]. Therefore, decisions regarding tube feeding (TF) in dementia without an advance directive remain ethically difficult for all people involved [3].

A systematic review evaluating the consequences of TF for patients with severe dementia reported no evidence of extension of survival time in patients receiving enteral TF [4], but the quality of the evidence is mostly poor and relatively old [5]. Recently, another systemic review stated that most studies found no harmful outcome with enteral nutrition use in patients with severe dementia [6], and improvement in nutrition and reduction of inflammation due to TF were reported by a study with long follow-up periods [7].

There have been a few reports dealing with pneumonia in severe dementia patients undergoing TF [8, 9]. The Japanese study revealed that the incidence of aspiration pneumonia in patients with a percutaneous endoscopic gastrostomy (PEG) tube was 9.4% after six months of TF, whereas it was 52.9% in patients with a nasogastric (NG) tube [8]. Among patients with aspiration pneumonia before PEG TF, 51.6% had a recurrence within 6 months after initiation of TF [8]. An Italian study comparing the frequency of aspiration pneumonia between patients with and without dementia found no differences between the two groups [9]. However, there have been no studies comparing the frequency of pneumonia in severe dementia between patients with and without TF. In this study, we examined the frequency of pneumonia before and after TF in severe dementia, and compared the occurrence of pneumonia between severe dementia patients with and without TF.

Methods

Design

This study retrospectively compared pre- and post-intervention incidences of pneumonia.

Setting and subjects

Almost all patients with behavioral and psychological symptoms of dementia (BPSD) are treated in psychiatric hospitals in Japan, and quite a few patients with dementia remain there long-term, even after BPSD are well controlled. Therefore, many dementia patients die in psychiatric hospitals in Japan.

We enlisted the member hospitals of the Association of Okayama Psychiatry Hospitals in a survey of inpatients undergoing artificial feeding. Of 20 psychiatric hospitals in Okayama Prefecture, three do not care for patients with dementia or psychiatric diseases in their chronic or terminal state. Nine of the remaining 17 agreed to participate in this survey.

All patients fulfilled following criteria. (i) They were inpatients in psychiatric hospitals in Okayama Prefecture. (ii) Oral intake was difficult for them. (iii) Attending physicians judged that long-term artificial nutrition was necessary for survival. (iv) The decision on whether or not to make use of long-term artificial nutrition was made by attending physicians between January 1, 2014 and December 31, 2014. (v) Patients suffering from terminal cancer were excluded.

Artificial nutrition

Artificial hydration and nutrition includes enteral and intravenous nutrition. Enteral nutrition mainly consists of NG and PEG TF, while intravenous nutrition comprises peripheral venous nutrition (PVN) and total parenteral nutrition (TPN). TPN is usually used in the terminal state of malignancy and now rarely used for long-term care at psychiatric hospitals in Japan [10]. Patients receiving TPN were not evaluated in this study. The patients in both groups (TF or PVN) were fed orally before initiation of TF or PVN, and all of them had difficulty in eating orally during the 12 weeks before the decision.

Almost all inpatients in a terminal state in Japan receive artificial nutrition, and this study included no cases in a terminal state receiving both enteral nutrition and intravenous nutrition. Therefore, in this study, all patients not ingesting feeding tube nutrition received PVN in addition to oral intake.

Clinical diagnosis

All patients with Alzheimer’s disease (AD) were diagnosed according to the criteria for probable AD formulated by the NIA-AA [11]. All patients with vascular dementia (VaD) met the criteria for probable VaD of the AHA-ASA [12]. Other disorders were diagnosed according to ICD-10 criteria.

Questionnaires

Clinical characteristics of patients including age, sex, clinical diagnosis, methods of artificial nutrition, and duration of artificial nutrition were surveyed. Questionnaires on all subjects were completed by geriatric psychiatrists who knew the patient well and were chiefly in charge of the participants being evaluated. All raters had daily contact with the individuals being studied.

All medical records including nursing records and temperature tables were thoroughly examined by geriatric psychiatrists. They also evaluated the severity of dementia at the time of the decision whether or not to make use of long-term artificial nutrition by using the clinical dementia rating (CDR) [13] and functional assessment staging test (FAST) [14]. Physical comorbidity was evaluated using the Charlson Comorbidity Index (CCI) [15].

In patients receiving TF, records for a maximum 12 weeks before and 12 weeks after the start of TF were considered. The number of days of hospitalization in the psychiatric hospital was counted. The number of days when fever of 38 degrees and over was recorded, the number of days when intravenous antibiotics were used, and the number of bouts pneumonia during the observation period were counted.

Statistics

Statistical analyses were performed using IBM SPSS Statistics 23.0. Student’s t-test was used to compare two independent groups. Comparisons of proportions between two independent groups were calculated using a chi square test (2 × 2 table). The values for the same patient between before and after the intervention were compared using a paired t-test. The survival time of each group was plotted as a Kaplan-Meier survival curve, and survival times of groups were compared using a log-rank test. The effects of several variables (TF or PVN, age, sex, CCI scores) on survival time were investigated using Cox proportional hazards regression analysis. All p values were two-tailed, and p < 0.05 was accepted as significant.

Results

Comparison of patients with and without TF

This study evaluated 58 patients (31 women and 27 men) (Table 1). The mean age of all patients was 79.6 ± 9.0 years. Clinical diagnoses are shown in Table 1. Of all subjects, patients with probable AD (n = 38) formed the biggest group, and those with VaD (n = 14) the second. The patients undergoing TF comprised those with a PEG tube (n = 20) and those with a NG tube (n = 26). All patients were scored as FAST 6e or over (Table 1).
Table 1

Comparison of patients with and without tube feeding (n = 58)

 

With tube

Without tube

  

n = 46

n = 12

t

p

Age (years) (mean ± S.D.)

78.4 ± 8.9

84.0 ± 8.1

1.962

0.055

CCI total

2.2 ± 1.1

2.5 ± 1.4

0.694

0.491

CDR SoB

17.4 ± 1.1

17.4 ± 1.2

0.188

0.851

   

χ2

p

Sex (men/women)

20/26

7/5

0.844

0.358

Diagnosis

 Alzheimer’s disease

30

8

  

 Vascular dementia

11

3

  

 Others

5

1

  

FAST

 6e

19

8

  

 7a

7

1

  

 7b

12

2

  

 7c

8

1

  

CDR, Personal Care

 2

1

0

  

 3

45

12

  

S.D. standard deviation, CCI Charlson Comorbidity Index, CDR clinical dementia rating, SoB sum of boxes

Survival curves of patients with and without TF are shown in Fig. 1. Patients with TF survived a median of 23 months and patients without TF survived two months. A log-rank test showed significantly longer survival of patients with TF than that of patients without TF (chi-square 33.018, p < 0.001). In Cox proportional hazards regression analysis, TF was associated with significantly longer survival (hazard ratio 9.8, 95% confidence interval 3.6–27.0, p < 0.001).
Fig. 1

Kaplan-Meier survival curves of patients with and without tube feeding

Comparison between before and after the beginning of TF

Pneumonia occurred more frequently in the 12 weeks before the start of TF than in the 12 weeks after (Table 2). Intravenous antibiotics were used on more days before the start of TF than after (Table 2). In patients without TF, no significant change in the frequency of pneumonia and antibiotic use was seen before and after the decision not to use TF (Table 2).
Table 2

Comparison between before and after decision for tube feeding (n = 58)

 

12 weeks before

12 weeks after

t

p

With tube feeding (n = 46)

 Obsevation days (mean ± S.D.)

70.3 ± 21.7

65.3 ± 24.0

1.124

0.267

 Pneumonia (number of bouts)

0.9 ± 0.9

0.4 ± 0.5

4.456

< 0.001

 Fever (days)

2.9 ± 4.3

1.9 ± 3.9

1.282

0.206

 Antibiotics (days)

11.8 ± 13.2

5.2 ± 7.4

3.308

0.002

Without tube feeding (n = 12)

 Obsevation days (mean ± S.D.)

68.6 ± 17.1

66.6 ± 22.1

0.248

0.809

 Pneumonia (number of bouts)

0.6 ± 0.7

0.7 ± 0.8

−0.266

0.795

 Fever (days)

1.5 ± 1.2

2.1 ± 3.1

−0.516

0.616

 Antibiotics (days)

1.4 ± 3.1

4.1 ± 7.0

−1.104

0.293

S.D. standard deviation, Antibiotics intravenous antibiotics

Of 18 patients without pneumonia in the observation period before TF, 4 (22%) suffered from pneumonia in the observation period after initiation of TF. Meanwhile, 16 of 28 patients (57%) with pneumonia in the observation period before TF did not suffer from pneumonia in the observation period after initiation of TF.

Comparison of patients with and without TF revealed no significant difference in the number of observation days (before and after decision for TF), bouts of pneumonia (before and after), days of fever (before and after), and days of antibiotic use (after) (Table 2). Days of antibiotic use in the 12 weeks before the decision for TF was higher in patients with TF than in patients without TF (Table 2).

Discussion

In this study, we evaluated the detailed state of patients with severe dementia at the start of tube nutrition, and found that patients with TF survived longer than those without TF. There have been few studies focusing on the stage of dementia severity when attending physicians decided whether or not to make use of long-term artificial nutrition for patients with severe dementia. Surprisingly, more than 40% of dementia patients started to receive TF at the FAST 6E stage in this study. In some reports, advanced dementia was defined as stage 7A or above on the FAST scale [4, 16]. If the category of FAST 7A or above is used to define advanced dementia, nearly half of dementia patients started to receive TF before they reached the advanced FAST 7A stage. Thus, we think that requiring stage FAST 7A or above for a diagnosis of advanced dementia is too strict.

The level of dementia severity of patients with and without TF was not investigated in most previous studies. The Cochrane review of TF for severe dementia patients includes seven studies [4]. In the study of Peck et al., 52 patients with TF all scored zero on MMSE, but only 71% of 52 patients without TF had dementia and scored <23 on MMSE [17]. In the study of Jaul et al., only 68% of patients with TF and 36% of those without TF were dementia patients. In other studies, only patients with severe dementia were included [18]. However, in those studies, numerous patients who did not need parenteral nutrition were included. It is improbable that patients who needed parenteral nutrition were physically or cognitively equal to those who did not need it. Therefore, there have been no studies in which dementia severity was scored for patients meeting the two following conditions: (i) attending physicians thought that the patients could not live without long-term artificial nutrition, and (ii) attending physicians decided whether or not to make use of long-term artificial nutrition. This study is the first trial to compare dementia patients from two groups with similar severity.

It was previously reported that PEG decreased the frequency of aspiration pneumonia in patients with dementia [8]. However, in that study, dementia severity was not estimated in detail. In this study, we first showed that TF decreased the frequency of pneumonia even in patients with severe dementia. On the other hand, in patients without TF, a decrease in the frequency of pneumonia and use of antibiotics was not observed after the decision not to use TF compared to the frequency before the decision not to use TF.

This study has several limitations. First, detailed laboratory findings at the start of artificial nutrition were not evaluated. Second, we did not collect data on clinical states such as quality of life after initiation of TF. Third, all subjects in this study were inpatients in psychiatric hospitals, and patients in nursing homes were not included. Therefore, we assume that subjects in this study are not representative of all dementia patients. Fourth, this study was not a randomized controlled study. Basically, patients whose conditions were too severe to permit TF were not included. However, it is probable that attending physicians might have tended to unconsciously select PVN for patients whose condition was too severe to benefit from TF. Therefore, the difference in physical severity between the two groups receiving PVN and receiving TF affected the difference in survival times between the two groups.

Conclusions

Enteral nutrition for patients with dementia prolongs survival and decreases the incidence of pneumonia. We think that this study provides the scientific bases on which an ethical decision should be made. Of course, we should differentiate what is from what should be. TF decreases the frequency of pneumonia even in severe dementia, but it does not mean that we should necessarily use TF for patients with severe dementia.

Abbreviations

AD: 

Alzheimer’s disease

BPSD: 

Behavioral and psychological symptoms of dementia

CCI: 

Charlson Comorbidity Index

CDR: 

Clinical dementia rating

FAST: 

Functional assessment staging test

NG: 

Nasogastric

PEG: 

Percutaneous endoscopic gastrostomy

PVN: 

Peripheral venous nutrition

TF: 

Tube feeding

TPN: 

Total parenteral nutrition

VaD: 

Vascular dementia

Declarations

Acknowledgements

We sincerely thank Ms. Yifei Tang and Ms. Sachiko Nagayama for their skillful assistance.

Funding

Data collection was supported by JSPS KAKENHI Grant Number 15 K09831 and 16 K10251. Writing and publication of this manuscript were supported by a research grant from the Zikei Institute of Psychiatry. The funders had no role in study design, data analysis, or decision to publish.

Availability of data and materials

The datasets and analyzed during the current study is available from the corresponding author on reasonable request.

Authors’ contributions

ST1 was involved in design of the study and data collection. He wrote the paper with ST2. ST2 designed the study and analyzed the data. KK, KO, AH, KT, KH, HA, KN, HI, HT, HNY, YS, KF and OY collected data and assisted with writing the paper. NY supervised the study design, participated in data analysis, and assisted with writing the paper. All authors read and approved the final manuscript.

Ethics approval and consent to participate

This study adhered to the 1975 Helsinki Declaration of Human Rights. The study protocol with a list of participating psychiatric hospitals was approved by the Internal Ethical Committee of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences (approval number: 1506–005).

All the hospitals taking part in this study agreed to be involved. All the participants completing the survey consented to be part of this study. The representative (geriatric psychiatrist) of this project at each hospital displayed posters on the bulletin board in the participating ward during the study period with an explanation of the project and informing patients and their families that they could decline to participate in this study. Participant consent was not required because data was de-identified prior to analysis.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
(2)
Department of Psychiatry, Sekizen Hospital
(3)
Department of Psychiatry, Hayashi Hospital
(4)
Department of Psychiatry, Kawada Hospital
(5)
Department of Psychiatry, Kibogaoka Hospital
(6)
Department of Psychiatry, Momonosato Hospital
(7)
Department of Psychiatry, Kohnan Hospital
(8)
Department of Psychiatry, Taiyo Hills Hospital
(9)
Department of Psychiatry, Zikei Hospital
(10)
Department of Psychiatry, Mannari Hospital
(11)
Department of Psychiatry, Kinoko Espoir Hospital

References

  1. Mitchell SLCLINICALPRACTICE. Advanced dementia. N Engl J Med. 2015;372(26):2533–40.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Clarke G, Harrison K, Holland A, Kuhn I, Barclay S. How are treatment decisions made about artificial nutrition for individuals at risk of lacking capacity? A systematic literature review. PLoS One. 2013;8(4):e61475.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Brooke J, Ojo O. Enteral nutrition in dementia: a systematic review. Nutrients. 2015;7(4):2456–68.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Sampson EL, Candy B, Jones L. Enteral tube feeding for older people with advanced dementia. Cochrane Database Syst Rev. 2009;2 CD007209.
  5. Harwood RH. Feeding decisions in advanced dementia. J R Coll Physicians Edinb. 2014;44(3):232–7.View ArticlePubMedGoogle Scholar
  6. Ribeiro Salomon AL. Carvalho Garbi Novaes MR. outcomes of enteral nutrition for patients with advanced dementia: a systematic review. J Nutr Health Aging. 2015;9(2):169–77.View ArticleGoogle Scholar
  7. Arinzon Z, Peisakh A, Berner YN. Evaluation of the benefits of enteral nutrition in long-term care elderly patients. J Am Med Dir Assoc. 2008;9(9):657–62.View ArticlePubMedGoogle Scholar
  8. Kumagai R, Kubokura M, Sano A, Shinomiya M, Ohta S, Ishibiki Y, Narumi K, Aiba M, Ichimiya Y. Clinical evaluation of percutaneous endoscopic gastrostomy tube feeding in Japanese patients with dementia. Psychiatry Clin Neurosci. 2012;66(5):418–22.View ArticlePubMedGoogle Scholar
  9. Venturini C, Sparvoli D, Jukic-Peladic N. OrlandoneP. Demented vs non demented patients: clinical outcomes and complications of home enteral nutrition among frail elderly patients (PP078-SUN). Clin Nutr Suppl. 2012;7(1):57.View ArticleGoogle Scholar
  10. Hirao A, Abe K, Takayama K, Kondo K, Yokota O, Sato Y, Norikiyo T, Sato S, Nakashima T, Hayashi H, et al. Heterogeneity of patients receiving artificial nutrition in Japanese psychiatric hospitals: a cross-sectional study. Psychogeriatrics. 2016;16(6):341–8.View ArticlePubMedGoogle Scholar
  11. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7(3):263–269.Google Scholar
  12. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(9):2672–713.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RLA. New clinical scale for the staging of dementia. Br J Psychiatry. 1982;140(6):566–72.View ArticlePubMedGoogle Scholar
  14. Reisberg B. Functional assessment staging (FAST). Psychopharmacol Bull. 1988;24(4):653–9.PubMedGoogle Scholar
  15. Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, Sundararajan V. Updating and validating the Charlson comorbidity index and score for risk adjustment in hos- pital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–82.View ArticlePubMedGoogle Scholar
  16. Alvarez-Fernández B, García-Ordoñez MA, Martínez-Manzanares C, Gómez-Huelgas R. Survival of a cohort of elderly patients with advanced dementia: nasogastric tube feeding as a risk factor for mortality. Int J Geriatr Psychiatry. 2005;20(4):363–70.View ArticlePubMedGoogle Scholar
  17. Peck A, Cohen CE, Mulvihill MN. Long-term enteral feeding of aged demented nursing home patients. J Am Geriatr Soc. 1990;38(11):1195–8.View ArticlePubMedGoogle Scholar
  18. Jaul E, Singer P, Calderon-Margalit R. Tube feeding in the demented elderly with severe disabilities. Isr Med Assoc J. 2006;8(12):870–4.PubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement